Top 10 Companies in the Gynostemma Extract Market (2026): Market Leaders Powering Global Wellness

MARKET INSIGHTS

Global Gynostemma Extract market size was valued at USD 158.7 million in 2024. The segment is projected to rise from USD 172.4 million in 2025 to USD 298.6 million by 2032, reflecting a compound annual growth rate of 7.2% over the forecast horizon.

Gynostemma extract, sourced from Gynostemma pentaphyllum, is a bioactive matrix rich in saponins (gypenosides) and flavonoids. Commonly dubbed “Southern Ginseng,” it is prized in traditional Chinese medicine for its adaptogenic capacity, supporting immune function, metabolic balance, and stress resilience. The extract appears in powder, liquid, capsule, and pill formats, enabling widespread application across pharmaceuticals, cosmetics, and functional foods.

Market momentum is driven by rising consumer demand for natural health supplements, particularly in North America and Europe where herbal extract sales have grown 12% annually since 2020. Regulatory complexity in certain jurisdictions, however, moderates expansion. Leading players such as Nutra Green Biotechnology and Novoherb Technologies are allocating resources to clinical trials, with three new human studies launched in Q1 2024 alone.

Gynostemma Extract Market – View in Detailed Research Report

PRODUCT DEFINITION

Gynostemma extract is a standardized botanical ingredient that delivers a consistent concentration of gypenosides and flavonoids. Its high solubility and stability make it a versatile base for nutraceutical powders, liquid tonics, encapsulated supplements, and oral tablets.

TOP 10 COMPANIES

🔟 1. Nutra Green Biotechnology

Headquarters: Shenzhen, China
Key Offering: High‑purity Gynostemma extract, standardized to 95% gypenosides

Nutra Green Biotechnology has positioned itself as the preeminent supplier for dietary supplement manufacturers, leveraging a vertically integrated supply chain that spans cultivation, extraction, and quality assurance. Its flagship product, a 95% standardized extract, is widely used in anti‑aging serums, cardiovascular supplements, and functional beverages.

Sustainability & Growth Initiatives:

• Investing in regenerative farming practices to secure long‑term herb yield
• Deploying blockchain traceability to guarantee source authenticity
• Partnering with universities to validate health claims through double‑blind trials

9️⃣ 2. Shaanxi Undersun Biomedtech

Headquarters: Xi’an, China
Key Offering: Supercritical CO₂ extracted Gynostemma, 98% purity

Shaanxi Undersun Biomedtech focuses on advanced extraction technology that preserves bioactive integrity while boosting yield. Its supercritical CO₂ process yields an ultra‑pure extract, making it attractive for high‑end nutraceuticals and pharmaceutical research.

Sustainability & Growth Initiatives:

• Reducing solvent waste by 30% through closed‑loop CO₂ recycling
• Developing a proprietary nano‑encapsulation platform to enhance bioavailability
• Securing ISO 9001 and ISO 14001 certifications to meet global compliance standards

8️⃣ 3. Novoherb Technologies

Headquarters: Chengdu, China
Key Offering: Standardized liquid extract, 90% gypenosides

Novoherb Technologies has built a reputation for delivering liquid extracts that retain full spectrum activity. The company’s focus on fluid formulations enables rapid absorption, positioning it as a preferred partner for functional drink manufacturers.

Sustainability & Growth Initiatives:

• Implementing precision agriculture to reduce pesticide usage by 25%
• Collaborating with global NGOs to promote fair‑trade sourcing
• Launching a digital platform for real‑time supply chain monitoring

7️⃣ 4. Mountain Rose Herbs

Headquarters: Portland, Oregon, USA
Key Offering: Organic, non‑GMO Gynostemma powder, 85% gypenosides

Mountain Rose Herbs supplies a certified organic extract that appeals to the clean‑label market. Its emphasis on transparency and eco‑friendly packaging resonates with environmentally conscious consumers.

Sustainability & Growth Initiatives:

• Adopting a zero‑waste manufacturing model
• Partnering with local farmers to support community‑based agriculture
• Offering a subscription service that rewards repeat buyers with reduced carbon footprints

6️⃣ 5. Xi’an Tianxingjan Bio-Products

Headquarters: Xi’an, China
Key Offering: High‑purity isolate, 95% gypenosides, 10 mg/mL concentration

Xi’an Tianxingjan Bio-Products delivers a concentrated isolate suitable for pharmaceutical formulations and high‑dose nutraceuticals. Its rigorous GMP compliance ensures reliability for clinical developers.

Sustainability & Growth Initiatives:

• Implementing renewable energy sources in production facilities
• Establishing a research partnership with a leading medical university for clinical trials
• Creating an open‑innovation portal for third‑party formulation development

5️⃣ 6. Huaian Chenhui Chemical

Headquarters: Huaian, China
Key Offering: Crude extract, 70% gypenosides, bulk quantity

Huaian Chenhui Chemical supplies cost‑effective crude extracts that serve manufacturers seeking volume at a lower price point. The company’s focus on large‑scale production keeps it competitive in price‑sensitive segments.

Sustainability & Growth Initiatives:

• Investing in water‑conserving extraction techniques
• Developing a low‑cost packaging line to reduce plastic waste
• Expanding into emerging markets through joint ventures

4️⃣ 7. Xi’an Natural Field Bio

Headquarters: Xi’an, China
Key Offering: Organic standardised extract, 90% gypenosides

Xi’an Natural Field Bio is committed to organic cultivation and extraction, positioning it as a trusted source for premium nutraceuticals and cosmetics. Its product line is often featured in high‑profile wellness brands.

Sustainability & Growth Initiatives:

• Implementing a closed‑loop water recycling system
• Engaging in community education programs on sustainable farming
• Launching a certification program for third‑party suppliers

3️⃣ 8. Green Leaf Biotech

Headquarters: Singapore
Key Offering: Nano‑encapsulated Gynostemma, 95% gypenosides

Green Leaf Biotech’s nano‑encapsulation technology enhances oral bioavailability, making its extract a preferred choice for high‑performance supplements and functional foods.

Sustainability & Growth Initiatives:

• Reducing carbon emissions by 40% through green energy sourcing
• Partnering with research institutes to develop next‑generation delivery systems
• Offering a transparent supply chain portal for end‑users

2️⃣ 9. Silicon Valley Nutraceuticals

Headquarters: San Francisco, USA
Key Offering: Clinical‑grade liquid extract, 85% gypenosides

Silicon Valley Nutraceuticals specializes in clinical‑grade formulations that meet stringent regulatory requirements, catering to medical‑grade supplement manufacturers.

Sustainability & Growth Initiatives:

• Adopting a zero‑waste policy in all production lines
• Funding clinical research through a dedicated grant program
• Implementing a carbon‑offset program for shipping logistics

1️⃣ 10. EcoHerb International

Headquarters: London, UK
Key Offering: Organic powder, 88% gypenosides, 100 kg bulk

EcoHerb International delivers large‑volume organic extracts to European manufacturers, emphasizing traceability and sustainability across its supply chain.

Sustainability & Growth Initiatives:

• Implementing a circular packaging system using recycled PET
• Partnering with local farms to promote biodiversity
• Launching an ESG reporting framework for investors

Download FREE Sample Report

Get Full Report

OUTLOOK

By 2034, the Gynostemma market is expected to reach USD 350 million, driven by expanding health‑tech ecosystems and increasing consumer awareness of adaptogenic benefits. Market concentration will shift towards high‑purity, clinically validated products, while price‑sensitive segments may consolidate around cost‑effective crude extracts.

FUTURE TRENDS

• Adoption of AI‑driven precision agriculture to optimize herb yield
• Growth of functional beverage lines featuring Gynostemma for metabolic support
• Emerging regulatory pathways for botanical therapeutics in the EU and US
• Integration of digital health platforms to personalize dosage recommendations
• Expansion into emerging markets through localized cultivation initiatives